Pine Pharmaceuticals, LLC: Drug Recall
Recall #D-0056-2024 · 10/02/2023
Class II: Risk
Recall Details
- Recall Number
- D-0056-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Pine Pharmaceuticals, LLC
- Status
- Terminated
- Date Initiated
- 10/02/2023
- Location
- Tonawanda, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2484 syringes
Reason for Recall
Lack of Assurance of Sterility
Product Description
Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Distribution Pattern
Nationwide within the United States
Other Recalls by Pine Pharmaceuticals, LLC
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.